Cerivastatin and the dissemination of adverse event information. [electronic resource]
- The Annals of pharmacotherapy Jun 2002
- 1099-103 p. digital
Publication Type: Journal Article
1060-0280
10.1345/aph.1A368 doi
Adverse Drug Reaction Reporting Systems--organization & administration Contraindications Databases, Factual Drug Approval Drug Labeling Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors--adverse effects Pharmacy--methods Pyridines--adverse effects Risk Assessment United States United States Food and Drug Administration--legislation & jurisprudence